|

STI-8591 Clinical Trials

1 actively recruiting trial

Also known as: STI-8591 alone

Pipeline

Phase 1: 1

Top Sponsors

  • Zhejiang ACEA Pharmaceutical Co. Ltd.1

Indications

  • AML, Adult1
  • Cancer1

Other1 trial

A Study to Evaluate the STI-8591 in Subjects With Advanced Acute Myeloid Leukemia (AML)
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.